Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance

Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16182-7. doi: 10.1073/pnas.0502828102. Epub 2005 Nov 1.

Abstract

Inhibitor of apoptosis (IAP) proteins, which bind to caspases via their baculoviral IAP repeat domains, also bear RING domains that enable them to promote ubiquitylation of themselves and other interacting proteins. Here we show that the RING domain of cIAP1 allows it to bind directly to the RING of X-linked IAP, causing its ubiquitylation and degradation by the proteasome, thus revealing a mechanism by which IAPs can regulate their abundance. Expression of a construct containing the RING of cellular IAP1 was able to deplete melanoma cells of endogenous X-linked IAP, promoted apoptosis, and also markedly reduced their clonogenicity when treated with cisplatin. Cross control of protein levels by RING domains may therefore enable their levels to be manipulated therapeutically.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Apoptosis
  • Caspases / physiology
  • Cell Line
  • Cell Survival
  • Cisplatin / therapeutic use
  • Homeostasis
  • Inhibitor of Apoptosis Proteins / metabolism*
  • Melanoma / drug therapy
  • Melanoma / pathology
  • Molecular Sequence Data
  • Proteasome Endopeptidase Complex / physiology
  • Protein Structure, Tertiary
  • Ubiquitin-Protein Ligases / physiology*
  • X-Linked Inhibitor of Apoptosis Protein / metabolism*

Substances

  • Inhibitor of Apoptosis Proteins
  • X-Linked Inhibitor of Apoptosis Protein
  • Ubiquitin-Protein Ligases
  • Caspases
  • Proteasome Endopeptidase Complex
  • Cisplatin